Clinical Efficacy of Adjuvant Therapy in Unresectable Gallbladder Cancer: our experience from south Punjab

dc.contributor.author	LUQMAN, ASIMA
dc.contributor.author	REHMAN, WAJIH-UR-
dc.contributor.author	RASOOL, SOHAIL ATTAUR
dc.contributor.author	RAZA, HASHIM
dc.contributor.author	HUSSAIN, SADIQ
dc.contributor.author	LUQMAN, SHOAIB
dc.date.accessioned	2022-10-27T03:30:48Z
dc.date.available	2022-10-27T03:30:48Z
dc.date.issued	2018-10
dc.identifier.issn	1996-7195
dc.identifier.uri	http://142.54.178.187:9060/xmlui/handle/123456789/13770
dc.description.abstract	Aim: Gallbladder carcinoma (GBC) commonly present at an advanced unresectable stage. We sought to compare efficacy of gemcitabine alone and in combination with radiotherapy as adjuvant treatment of GBC. Study Design: Quasi-experimental study. Place & Duration of Study: Nishtar Hospital Multan from July 2012 to June 2013. Methods: Fourty six confirmed cases of unresectable GBC were randomly allocated in two groups. Group-I received gemcitabine alone and Group-II received gemcitabine and radiotherapy. Results: Combination of gemcitabine and radiotherapy achieved better clinical efficacy as adjuvant treatment. Conclusions: Radiation therapy using Gemcitabine as radiosensitizer is more beneficial in control of disease.	en_US
dc.language.iso	en_US	en_US
dc.publisher	Pakistan Journal of Medical and Health Sciences	en_US
dc.subject	Gallbladder carcinoma	en_US
dc.subject	gemcitabine	en_US
dc.subject	radiotherapy	en_US
dc.title	Clinical Efficacy of Adjuvant Therapy in Unresectable Gallbladder Cancer: our experience from south Punjab	en_US
dc.type	Article	en_US